Event
BIOE Seminar: Hannah Zierden (University of Maryland)
Friday, May 6, 2022
9:00 a.m.-10:00 a.m.
Virtual
Shawn He
shawnhe@umd.edu
Hannah Zierden
Assistant Professor
Chemical and Biomolecular Engineering Department
Nanotechnology for the prevention and understanding of preterm birth
This event will be offered in a virtual format. Login details will be sent to current BIOE faculty, affiliates, students, postdocs, and those who have previously asked to subscribe to our seminars listserv. If you do not currently receive our weekly seminars emails but you wish to attend this event, please email Alyssa Tomlinson (awolice@umd.edu).
Speaker Bio
Hannah Zierden is an incoming Assistant Professor in the Chemical and Biomolecular Engineering Department at The University of Maryland. She is currently finishing her postdoctoral research at The University of Maryland School of Medicine, working under the supervision of Professor Tracy Bale. In the Bale lab, Hannah has investigated the role of placenta-derived extracellular vesicles in communicating maternal stress signals to developing offspring. Prior to the Bale Lab, Hannah earned her Ph.D. at Johns Hopkins University in chemical and biomolecular engineering in 2020, working with Drs. Laura Ensign and Justin Hanes. During her thesis work, she engineered nanoparticle formulations for the prevention of preterm birth, highlighting the importance of effective drug delivery to understand drug action and effectiveness in human disease. Hannah earned her B.S. degree in chemical and biomolecular engineering from The Ohio State University in 2011. Her research has been published in peer-reviewed journals, and presented at national and international conferences. Hannah was a 2021 MIT Rising Star in Chemical Engineering, a 2017 NSF Graduate Research Fellow, and is involved with the AIChE Women in Chemical Engineering Committee and the Controlled Release Society’s Young Scientists Committee.
The Zierden lab will utilize a highly interdisciplinary approach to ask how both mammalian and bacterial extracellular vesicles contribute pregnancy outcomes, and how these biological nanoparticles may be used as therapeutics for maternal and fetal health indications.
